← Eichor
Study identifier: NCT07022990 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Improving Medication Management in World Trade Center Responders

Condition: Polypharmacy  ·  Sponsor: Icahn School of Medicine at Mount Sinai

PhaseNA
Planned participants50
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersNo

About this study

By 2030, the majority of World Trade Center (WTC) rescue and recovery workers (responders) will be aged 65 and over and at risk for aging-related conditions and consequences including the concurrent use of five or more medications (i.e., polypharmacy). The purpose of this research study is to investigate an educational approach targeting polypharmacy through de-prescribing unnecessary and burdensome medications via the support of informed discussions between WTC responders and their prescribing physicians.

This description comes directly from the study's public registry record.

Talk to the study team

Patricia Kim  ·  212-241-9370  ·  patricia.kim@mssm.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Icahn School of Medicine at Mount SinaiNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07022990